{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:36:05Z","timestamp":1780378565103,"version":"3.54.1"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Patients with the severe form of hemophilia A (HA) present with a severe phenotype, and can suffer from life-threatening, spontaneous hemorrhaging. While prophylactic FVIII infusions have revolutionized the clinical management of HA, this treatment is short-lived, expensive, and it is not available to many A patients worldwide. In the present study, we evaluated a panel of readily available cell types for their suitability as cellular vehicles to deliver long-lasting FVIII replacement following transduction with a retroviral vector encoding a B domain-deleted human F8 transgene. Given the immune hurdles that currently plague factor replacement therapy, we focused our investigation on cell types that we deemed to be most relevant to either prenatal or very early postnatal treatment and that could, ideally, be autologously derived. Our findings identify several promising candidates for use as cell-based FVIII delivery vehicles and lay the groundwork for future mechanistic studies to delineate bottlenecks to efficient production and secretion of FVIII following genetic-modification.<\/jats:p>","DOI":"10.3389\/fcell.2021.678117","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T06:29:22Z","timestamp":1628576962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A"],"prefix":"10.3389","volume":"9","author":[{"given":"Christopher","family":"Stem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu M.","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Meares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Farland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Atala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Doering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Trent","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Porada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a","family":"Almeida-Porada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2016.20","article-title":"In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.","volume":"5","author":"Almeida-Porada","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ymthe.2019.02.015","article-title":"In utero gene therapy consensus statement from the IFeTIS.","volume":"27","author":"Almeida-Porada","year":"2019","journal-title":"Mol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3727\/096368910x539074","article-title":"Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy.","volume":"20","author":"Antonucci","year":"2011","journal-title":"Cell Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/sctm.16-0297","article-title":"First characterization of human amniotic fluid stem cell extracellular vesicles as a powerful paracrine tool endowed with regenerative potential.","volume":"6","author":"Balbi","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1089\/scd.2010.0424","article-title":"Amniotic fluid stem cells are cardioprotective following acute myocardial infarction.","volume":"20","author":"Bollini","year":"","journal-title":"Stem Cells Dev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12015-010-9200-z","article-title":"In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells.","volume":"7","author":"Bollini","year":"","journal-title":"Stem Cell Rev."},{"key":"B7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpedsurg.2013.09.043","article-title":"In utero repair of myelomeningocele with autologous amniotic membrane in the fetal lamb model.","volume":"49","author":"Brown","year":"2014","journal-title":"J. Pediatr. Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"24451","DOI":"10.1074\/jbc.m111.238758","article-title":"Enhanced biosynthesis of coagulation factor VIII through diminished engagement of the unfolded protein response.","volume":"286","author":"Brown","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.36","article-title":"Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery.","volume":"1","author":"Brown","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.omtm.2018.01.004","article-title":"Target-cell-directed bioengineering approaches for gene therapy of hemophilia A.","volume":"9","author":"Brown","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/cvi.05107-11","article-title":"Adeno-associated virus antibody profiles in newborns, children, and adolescents.","volume":"18","author":"Calcedo","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00341","article-title":"Humoral immune response to AAV.","volume":"4","author":"Calcedo","year":"2013","journal-title":"Front. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2017.278101","article-title":"Noninvasive prenatal diagnosis of single-gene disorders by use of droplet digital PCR.","volume":"64","author":"Camunas-Soler","year":"2018","journal-title":"Clin. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/hep.21899","article-title":"Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep.","volume":"46","author":"Chamberlain","year":"2007","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1089\/scd.2014.0516","article-title":"Isolation of human neural stem cells from the amniotic fluid with diagnosed neural tube defects.","volume":"24","author":"Chang","year":"2015","journal-title":"Stem Cells Dev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40259-017-0255-0","article-title":"Gene therapy for hemophilia: progress to date.","volume":"32","author":"Chapin","year":"2018","journal-title":"BioDrugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.exphem.2008.02.007","article-title":"Early fetal gene delivery utilizes both central and peripheral mechanisms of tolerance induction.","volume":"36","author":"Colletti","year":"2008","journal-title":"Exp. Hematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.scr.2008.08.002","article-title":"Generation of tissue-specific cells by MSC does not require fusion or donor to host mitochondrial\/membrane transfer.","volume":"2","author":"Colletti","year":"2009","journal-title":"Stem Cell Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/j.1582-4934.2012.01617.x","article-title":"Perivascular cells for regenerative medicine.","volume":"16","author":"Crisan","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1182\/blood-2006-05-022756","article-title":"VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.","volume":"109","author":"Dasgupta","year":"2007","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171132","article-title":"Induction of immune tolerance to foreign protein via adeno-associated viral vector gene transfer in mid-gestation fetal sheep.","volume":"12","author":"Davey","year":"2017","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nbt1274","article-title":"Isolation of amniotic stem cell lines with potential for therapy.","volume":"25","author":"De Coppi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/mt.2009.35","article-title":"Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.","volume":"17","author":"Doering","year":"2009","journal-title":"Mol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"38345","DOI":"10.1074\/jbc.m206959200","article-title":"High level expression of recombinant porcine coagulation factor VIII.","volume":"277","author":"Doering","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1074\/jbc.m312451200","article-title":"Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.","volume":"279","author":"Doering","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/hum.2008.150","article-title":"Comparison of factor VIII transgenes bioengineered for improved expression in gene therapy of hemophilia A.","volume":"20","author":"Dooriss","year":"2009","journal-title":"Hum. Gene. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.omtm.2020.03.001","article-title":"Defining the optimal FVIII transgene for placental cell-based gene therapy to treat hemophilia A.","volume":"17","author":"El-Akabawy","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1182\/blood-2014-02-555151","article-title":"A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.","volume":"123","author":"Fahs","year":"2014","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.placenta.2012.03.009","article-title":"Derivation and characterization of progenitor stem cells from canine allantois and amniotic fluids at the third trimester of gestation.","volume":"33","author":"Fernandes","year":"2012","journal-title":"Placenta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.omtm.2018.02.003","article-title":"Influence of pre-existing anti-capsid neutralizing and binding antibodies on AAV vector transduction.","volume":"9","author":"Fitzpatrick","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/hae.12690","article-title":"Haemophilia A carriers experience reduced health-related quality of life.","volume":"21","author":"Gilbert","year":"2015","journal-title":"Haemophilia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bbagen.2012.02.001","article-title":"Diseases of glycosylation beyond classical congenital disorders of glycosylation.","volume":"1820","author":"Hennet","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaci.2011.08.029","article-title":"Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain.","volume":"129","author":"Herczenik","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1182\/blood-2012-05-423210","article-title":"The gene therapy journey for hemophilia: are we there yet?","volume":"120","author":"High","year":"2012","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1182\/blood-2016-12-755017","article-title":"Noninvasive detection of F8 int22h-related inversions and sequence variants in maternal plasma of hemophilia carriers.","volume":"130","author":"Hudecova","year":"2017","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1182\/blood-2007-04-082602","article-title":"Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.","volume":"110","author":"Ide","year":"2007","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","article-title":"Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.","volume":"104","author":"Ingram","year":"2004","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4252\/wjsc.v6.i4.404","article-title":"Fetal stem cell transplantation: past, present, and future.","volume":"6","author":"Ishii","year":"2014","journal-title":"World J. Stem Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.22203\/ecm.v037a10","article-title":"Large-scale secretome analyses unveil the superior immunosuppressive phenotype of umbilical cord stromal cells as compared to other adult mesenchymal stromal cells.","volume":"37","author":"Islam","year":"2019","journal-title":"Eur. Cell. Mater."},{"key":"B40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/gt.2012.76","article-title":"Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.","volume":"20","author":"Johnston","year":"2013","journal-title":"Gene Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/gt.2014.80","article-title":"High-throughput screening identifies compounds that enhance lentiviral transduction.","volume":"21","author":"Johnston","year":"2014","journal-title":"Gene Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2516.2007.01575.x","article-title":"Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.","author":"Kaveri","year":"2007","journal-title":"Haemophilia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/sctm.18-0018","article-title":"Amniotic fluid stem cells for the treatment of surgical disorders in the fetus and neonate.","volume":"7","author":"Kunisaki","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"B44","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0049-3848(08)70002-1","article-title":"The role of VWF in the immunogenicity of FVIII.","author":"Lacroix-Desmazes","year":"2008","journal-title":"Thromb. Res."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2016.64","article-title":"Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice.","volume":"3","author":"Lange","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1038\/srep29994","article-title":"The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity.","volume":"6","author":"Lazzarini","year":"2016","journal-title":"Sci. Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1538-7836.2007.02572.x","article-title":"Clearance mechanisms of von Willebrand factor and factor VIII.","volume":"5","author":"Lenting","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"B48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/gt.2011.90","article-title":"Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.","volume":"19","author":"Li","year":"2012","journal-title":"Gene Ther."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123350","article-title":"Characteristics of human amniotic fluid mesenchymal stem cells and their tropism to human ovarian cancer.","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/s0025-6196(12)62395-7","article-title":"The association of factor VIII with von Willebrand factor.","volume":"66","author":"Lollar","year":"1991","journal-title":"Mayo Clin. Proc."},{"key":"B51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0034-1382260","article-title":"In utero stem cell and gene therapy: current status and future perspectives.","volume":"24","author":"Loukogeorgakis","year":"2014","journal-title":"Eur. J. Pediatr. Surg."},{"key":"B52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.15283\/ijsc.2014.7.2.118","article-title":"Comparison of mesenchymal stem cell markers in multiple human adult stem cells.","volume":"7","author":"Maleki","year":"2014","journal-title":"Int. J. Stem Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"18525","DOI":"10.1073\/pnas.0809677105","article-title":"Antioxidants reduce endoplasmic reticulum stress and improve protein secretion.","volume":"105","author":"Malhotra","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00441-015-2185-9","article-title":"Comparative study between amniotic-fluid mesenchymal stem cells and retinal pigmented epithelium (RPE) stem cells ability to differentiate towards RPE cells.","volume":"362","author":"Mariotti","year":"2015","journal-title":"Cell Tissue Res."},{"key":"B55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18388\/abp.2015_1056","article-title":"The factor VIII protein and its function.","volume":"63","author":"Mazurkiewicz-Pisarek","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bpobgyn.2015.08.006","article-title":"In utero stem cell transplantation and gene therapy: recent progress and the potential for clinical application.","volume":"31","author":"McClain","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.stemcr.2016.05.009","article-title":"Boosting hematopoietic engraftment after in utero transplantation through vascular niche manipulation.","volume":"6","author":"Mokhtari","year":"2016","journal-title":"Stem Cell Rep."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026535","article-title":"Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response.","volume":"6","author":"Moorefield","year":"2011","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0032-1331799","article-title":"Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells.","volume":"31","author":"Murphy","year":"2013","journal-title":"Semin. Reprod. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1182\/blood-2015-03-636803","article-title":"Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants.","volume":"126","author":"Peranteau","year":"2015","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/j.1538-7836.2005.01367.x","article-title":"The promise and challenges of bioengineered recombinant clotting factors.","volume":"3","author":"Pipe","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"B62","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-09-3879","article-title":"Bleeding in carriers of hemophilia.","volume":"108","author":"Plug","year":"2006","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3727\/096368910x536518","article-title":"Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion.","volume":"20","author":"Poloni","year":"2011","journal-title":"Cell Transplant."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.addr.2010.08.010","article-title":"Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.","volume":"62","author":"Porada","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B65","article-title":"Treatment of hemophilia A in utero and postnatally using sheep as a model for cell and gene delivery.","author":"Porada","year":"2012","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"B66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000074255","article-title":"The sheep model of in utero gene therapy.","volume":"19","author":"Porada","year":"2004","journal-title":"Fetal Diagn. Ther."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00276","article-title":"Hemophilia A: an ideal disease to correct in utero.","volume":"5","author":"Porada","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B68","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.exphem.2011.09.001","article-title":"Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.","volume":"39","author":"Porada","year":"2011","journal-title":"Exp. Hematol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"526","DOI":"10.18043\/ncm.74.6.526","article-title":"Gene therapy: the promise of a permanent cure.","volume":"74","author":"Porada","year":"2013","journal-title":"N. C. Med. J."},{"key":"B70","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1182\/blood-2017-05-786269","article-title":"Prenatal diagnosis by droplet digital PCR.","volume":"130","author":"Ragni","year":"2017","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00270","article-title":"In utero therapy for congenital disorders using amniotic fluid stem cells.","volume":"5","author":"Ramachandra","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/nejmoa1708483","article-title":"AAV5-factor VIII gene transfer in severe hemophilia A.","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1172\/jci1250","article-title":"Intracellular trafficking of factor VIII to von Willebrand factor storage granules.","volume":"101","author":"Rosenberg","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/jcp.24247","article-title":"Mesenchymal stem cells contribute to endogenous FVIII:c production.","volume":"228","author":"Sanada","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-019-1376-9","article-title":"Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation.","volume":"10","author":"Selich","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5966\/sctm.2014-0224","article-title":"Fetal endothelial and mesenchymal progenitors from the human term placenta: potency and clinical potential.","volume":"4","author":"Shafiee","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.stemcr.2018.01.011","article-title":"Meso-endothelial bipotent progenitors from human placenta display distinct molecular and cellular identity.","volume":"10","author":"Shafiee","year":"2018","journal-title":"Stem Cell Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2009-07-232546","article-title":"Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool.","volume":"115","author":"Shahani","year":"2010","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/jth.12412","article-title":"Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII.","volume":"12","author":"Shahani","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3727\/096368910x543402","article-title":"Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses.","volume":"20","author":"Shaw","year":"","journal-title":"Cell Transplant."},{"key":"B81","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/gco.0b013e32834457b1","article-title":"Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid.","volume":"23","author":"Shaw","year":"","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3727\/096368916x691006","article-title":"Autologous transplantation of amniotic fluid-derived mesenchymal stem cells into sheep fetuses.","volume":"25","author":"Shaw","year":"2016","journal-title":"Cell Transplant."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1182\/blood-2010-03-272419","article-title":"Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.","volume":"116","author":"Shi","year":"2010","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036163","article-title":"Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins.","volume":"7","author":"Soland","year":"2012","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/mt.2010.239","article-title":"Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII.","volume":"19","author":"Spencer","year":"2011","journal-title":"Mol. Ther."},{"key":"B86","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc01e02s1","article-title":"Isolation of mesenchymal stem cells from amniotic fluid and placenta.","volume":"1","author":"Steigman","year":"2007","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/b978-0-12-812015-6.00001-7","article-title":"In utero therapy for congenital disorders using amniotic fluid stem cells","author":"Subramaniam","year":"2018","journal-title":"Perinatal Stem Cells"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123712","article-title":"Immune tolerance induction using fetal directed placental injection in rodent models: a murine model.","volume":"10","author":"Takahashi","year":"2015","journal-title":"PLoS One"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","article-title":"Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance.","volume":"16","author":"Terraube","year":"2010","journal-title":"Haemophilia"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1182\/blood.v97.11.3417","article-title":"Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses.","volume":"97","author":"Tran","year":"2001","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.639070","article-title":"Effects of shear stress on production of FVIII and vWF in a cell-based therapeutic for hemophilia A.","volume":"9","author":"Trevisan","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B92","first-page":"498","article-title":"In utero haematopoietic stem cell transplantation. Experiences in mice, sheep and humans.","volume":"136","author":"Troeger","year":"2006","journal-title":"Swiss Med. Wkly."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1182\/blood-2010-10-310789","article-title":"Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA.","volume":"117","author":"Tsui","year":"2011","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1182\/blood-2002-03-0779","article-title":"In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor.","volume":"101","author":"Waddington","year":"2003","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1182\/blood-2004-02-0627","article-title":"Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy.","volume":"104","author":"Waddington","year":"2004","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v110.11.3714.3714","article-title":"Human cord blood-derived endothelial progenitor cells engraft following in utero transplantation, integrate into the developing cytoarchitecture and contribute to ongoing vasculogenesis.","volume":"110","author":"Wood","year":"2007","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v112.11.1883.1883","article-title":"Human endothelial progenitor cells: a novel and promising cellular therapy for regenerating intestinal mucosa.","volume":"112","author":"Wood","year":"2008","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/hep.25753","article-title":"Distinct contribution of human cord blood-derived endothelial colony forming cells to liver and gut in a fetal sheep model.","volume":"56","author":"Wood","year":"2012","journal-title":"Hepatology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/cbin.10037","article-title":"Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice.","volume":"37","author":"Yang","year":"2013","journal-title":"Cell Biol. Int."},{"key":"B100","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/gutjnl-2012-303735","article-title":"Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism.","volume":"63","author":"Zani","year":"2014","journal-title":"Gut"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2016.63","article-title":"Potential for cellular stress response to hepatic factor VIII expression from AAV vector.","volume":"3","author":"Zolotukhin","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.678117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T06:29:41Z","timestamp":1628576981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.678117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":101,"alternative-id":["10.3389\/fcell.2021.678117"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.678117","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"article-number":"678117"}}